Loading
A phase 2 trial of cadonilimab, fluorouracil, leucovorin and liposomal irinotecan in gallbladder cancer and other biliary tract cancers, run by West China Hospital, now recruiting.
Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma is a phase 2 interventional study registered as NCT06438822 by West China Hospital, with a registry enrolment figure of 51 participants, started 2024-08-30 and due to reach its primary completion in 2026-08-30. Interventions recorded: Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil. Conditions listed: Cholangiocarcinoma. Gallbladder cancer is named in the registry entry: "1. Diagnosed with pathologically confirmed locally advanced unresectable or metastatic adenocarcinoma of the bile ducts, gallbladder, or cholangiocellular carcinoma, with primary tumors located in the intrahepatic bile d". Sites: China. No results are recorded here; the registry entry is the source.
Shares Liposomal irinotecan, Leucovorin (folinic acid), Extrahepatic cholangiocarcinoma (perihilar and distal), Intrahepatic cholangiocarcinoma and the tag gallbladder-deep-dive.
Shares Cadonilimab, Extrahepatic cholangiocarcinoma (perihilar and distal), Intrahepatic cholangiocarcinoma, Gallbladder cancer in biliary tract cancer trials (eligibility and subgroups) and the tag gallbladder-deep-dive.
Shares Liposomal irinotecan, Extrahepatic cholangiocarcinoma (perihilar and distal), Intrahepatic cholangiocarcinoma, Gallbladder cancer in biliary tract cancer trials (eligibility and subgroups) and the tag gallbladder-deep-dive.
Shares Liposomal irinotecan, Leucovorin (folinic acid), Gallbladder cancer in biliary tract cancer trials (eligibility and subgroups), Fluorouracil (5-FU) and the tag gallbladder-deep-dive.
Shares Liposomal irinotecan, Gallbladder cancer in biliary tract cancer trials (eligibility and subgroups), Bispecific antibodies, Fluorouracil (5-FU) and the tag gallbladder-deep-dive.
Shares Leucovorin (folinic acid), Extrahepatic cholangiocarcinoma (perihilar and distal), Intrahepatic cholangiocarcinoma, Gallbladder cancer in biliary tract cancer trials (eligibility and subgroups) and the tag gallbladder-deep-dive.
Shares Leucovorin (folinic acid), Extrahepatic cholangiocarcinoma (perihilar and distal), Intrahepatic cholangiocarcinoma, Gallbladder cancer in biliary tract cancer trials (eligibility and subgroups) and the tag gallbladder-deep-dive.
Shares Extrahepatic cholangiocarcinoma (perihilar and distal), Intrahepatic cholangiocarcinoma, Gallbladder cancer in biliary tract cancer trials (eligibility and subgroups), Biliary tract cancer (cholangiocarcinoma) and the tag gallbladder-deep-dive.